Living donor liver transplantation: Summary of a conference at The National Institutes of Health

Liver Transplantation

Volumn 8, Issue 2, 2002, Pages 174-188

  Shiffman, Mitchell L ^{a,b,c,d,e,f,g}   Brown Jr , Robert S ^{a,b,c,d,e,f,g}   Olthoff, Kim M ^{a,b,c,d,e,f,g}   Everson, Gregory ^{a,b,c,d,e,f,g}   Miller, Charles ^{a,b,c,d,e,f,g}   Siegler, Mark ^{a,b,c,d,e,f,g}   Hoofnagle, Jay H ^{a,b,c,d,e,f,g}  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e MOUNT SINAI HOSPITAL   (United States)

^f UNIVERSITY OF CHICAGO   (United States)

^g NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; HUMAN; LIVER TRANSPLANTATION; LIVING DONOR; MORBIDITY; ORGAN DONOR; PRIORITY JOURNAL; RISK ASSESSMENT; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL; UNITED STATES; WORKSHOP;

EID: 0036193053     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2002.30981     Document Type: Article

References (115)

1. Increased waiting time for liver transplantation results in higher mortality
2. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
3. The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States
4. The impact of donor age on liver transplantation: Influence of donor age on early liver function and on subsequent patient and graft survival
5. Influence of donor criteria on postoperative graft function after orthotopic liver transplantation
6. Transmission of hepatitis B infection from hepatitis B core antibody-positive livers: Background and prevention
7. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts
8. 2,500 Living donor kidney transplants: A single-center experience
9. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts and living related segmental transplants
10. Segmental orthotopic hepatic transplantation as a means to improve patient survival and diminish waiting list mortality
11. Improved results of living-related liver transplantation with routine application in a pediatric program
12. Liver transplantation in children from living related donors
13. Pediatric liver transplantation with cadaveric or living related donors: Comparative results in 90 elective recipients of primary grafts
14. Liver transplantation using a right lobe graft from a living related donor
15. Adult living donor liver transplantation using the right lobe
16. An Introduction to Greek mythology: Story, Symbols, and Culture Based on the Lectures of John M. Bell
17. Liver regeneration
18. Liver regeneration
19. Human liver regeneration after major hepatectomy. A study of liver volume by computed tomography
20. Liver regeneration: An overview
21. Duration of liver ischemia and hepatic regeneration after hepatectomy in rats
22. Evidence that host size determines liver size: Studies in dogs receiving orthotopic liver transplants
23. Liver regeneration after orthotopic reduced-size hepatic transplantation in the rat
24. Small-for-size liver transplanted into larger recipient: A model of hepatic regeneration
25. Liver regeneration in recipients and donors after transplantation
26. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation
27. Studies on the mechanisms of augmentation of liver regeneration by cyclosporine and FK506
28. Transcriptional regulatory signals define cytokine-dependent and independent pathways in liver regeneration
29. Cytokine regulation of liver injury and repair
30. Liver regeneration: Signal transduction during liver regeneration
31. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice
32. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice
33. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent
34. Ischemia impairs liver regeneration after major tissue loss in rodents: Protective effects of interleukin-6
35. Activation of interleukin-6/STAT3 and liver regeneration following transplantation
36. Effect of glucocorticoid on liver regeneration after partial hepatectomy in the rat
37. Glucocorticoids inhibit progression of cell cycle pathways following ischemia/reperfusion injury in the liver
38. Mechanisms of ischemic injury are different in the steatotic and normal rat liver
39. Failure of regeneration of the steatotic rat liver: Disruption at two different levels in the regeneration pathway
40. Dynamics of normal and injured human liver regeneration after hepatectomy as assessed on the basis of computed tomography and liver function
41. Human liver regeneration after major hepatectomy: A study of liver volume by computed tomography
42. Experimental pathology of the liver: Restoration of the liver of the white rat following partial surgical removal
43. The minimal graft size for successful orthotopic partial liver transplantation in the canine model
44. Study of donor-recipient liver size match for transplantation
45. Alopecia, ascites and incomplete regeneration after 85 to 90 percent resection
46. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume
47. Calculation of child and adult standard liver volume for liver transplantation
48. Minimum graft size for successful living donor liver transplantation
49. Impact of graft size mismatching on graft prognosis in liver transplantation from living donor
50. Graft size assessment by preoperative computed tomography in living related partial liver transplantation
51. Accuracy and utility of 3-dimensional computed tomography in evaluating donors for adult living related liver transplantation
52. Right lobe living donor liver transplantation: Preoperative evaluation of the donor with MR imaging
53. Graft mass and volume calculation in living related donors for liver transplantation
54. Preoperative measurement of segmental liver volume of donors for living related liver transplantation
55. Use of fatty donor liver is associated with diminished early patient and graft survival
56. Risk factors for primary dysfunction after liver transplantation - A multivariate analysis
57. Primary nonfunction of hepatic allografts with preexisting fatty infiltration
58. Hepatic steatosis as a potential risk factor for major hepatic resection
59. Right lobe living donor liver transplantation
60. Body mass index as a predictor of hepatic steatosis in living liver donors
61. Living related liver transplantation in adults
62. Single center analysis of the first 40 adult-to-adult living donor liver transplants using the right lobe
63. Adult-to-adult living donor liver transplantation using right-lobe grafts: Results and lessons learned from a single-center experience
64. Living donor liver transplantation in adults: Outcome in Europe
65. Living donor liver transplantation in adults. Outcome in Japan
66. Adult-to-adult living donor liver transplantation using extended right lobe grafts
67. Right lobe graft in living donor liver transplantation
68. Living-donor liver transplantation in adults
69. Surgical anatomy of the liver and its application to hepatobiliary surgery and transplantation
70. Surgical anatomy of the left lateral segment as applied to living-donor and split-liver transplantation: A clinicopathologic study
71. Hepatic arterial anatomy as applied to living-donor and split-liver transplantation
72. Right-lobe living donor liver transplantation. A review
73. Technical challenges of hepatic venous outflow reconstruction in right lobe adult living donor liver transplantation
74. Technical refinements in adult-to-adult living donor liver transplantation using right lobe graft
75. Increased risk for living donors after extended right lobectomy
76. Use of imaging for living donor liver transplantation
77. Angiographic selection criteria for living related liver transplant donors
78. Use of intra-operative Doppler ultrasound to diagnose hepatic venous obstruction in a right lobe living donor liver transplant
79. Hepatic artery complications after liver transplantation
80. Safety of donors in live donor liver transplantation using right lobe grafts
81. Hepatic artery thrombosis in living related liver transplantation
82. Reconstruction of double hepatic arterial and portal venous branches for right lobe living donor liver transplantation
83. Whither living donor liver transplantation?
84. Deaths after living related liver transplantation
85. Complications in 100 living-liver donors
86. Analysis of the risk and operative stress for donors in living-related partial liver transplantation
87. Selection of the living liver donor
88. Safety of the donor in living-related liver transplantation-An analysis of 100 parental donors
89. Adult living donor liver transplantation in the US: Results of the survey from the NIH meeting
90. Consensus statement on the live donor
91. Selection and outcome of living donors for adult to adult right lobe transplantation
92. Evaluation of 100 patients for living donor liver transplantation
93. Analysis of the postoperative function of donors in living-related liver transplantation
94. Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association of the Study of Liver Diseases
95. Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association of the Study of Liver Diseases
96. Living donor liver transplantation for fulminant hepatic failure
97. Successful living related liver transplantation in adults with fulminant hepatic failure
98. Emergency adult to adult living donor liver transplantation for fulminant hepatic failure
99. Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure
100. Rising incidence of hepatocellular carcinoma in the United States
101. Hepatitis C associated hepatocellular carcinoma
102. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States
103. A model to predict survival in patients with end-stage liver disease
104. Surgery and transplantation for hepatocellular carcinoma
105. Liver transplantation for malignant disease
106. Ethics of liver transplantation with living donors
107. The ethical assessment of innovative therapies: Liver transplantation using living donors
108. Quality of life among donors of liver transplants to relatives
109. Right hepatic lobe donation for living donor liver transplantation: Impact on donor quality of life
110. Donor quality of life after adult liver transplant donation
111. Comparison of the pre-transplant costs and medical acuity between adult cadaveric versus live-donor liver transplant recipients
112. Charge comparison of living donor right lobe liver transplantation versus cadaveric donor liver transplantation
113. A comparison of charges for organ acquisition: Adult cadaveric vs adult living donor liver transplantation
114. Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective